Yet now, as the coronavirus pandemic spreads around the world, consuming global health resources, these perennially neglected adversaries are making a comeback. It’s not just that the coronavirus has diverted scientific attention from TB, HIV and malaria. Lockdowns and supply-chain disruptions amid the coronavirus pandemic threaten progress against tuberculosis as well as HIV and malaria. Cepheid, the California-based manufacturer of TB diagnostic tests, has pivoted to making tests for the coronavirus. Coronavirus tests are much more lucrative, at about $10, compared with 18 cents for a rapid malaria test.

Source: bd News24 August 04, 2020 15:00 UTC